A Phase 2, Randomized Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914 on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women.
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 16 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 22 Feb 2013 Planned end date changed from 1 Sep 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned end date changed from 1 May 2009 to 1 Sep 2011 as reported by ClinicalTrials.gov.